You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Treatment of Sepsis with Talactoferrin
SBC: AGENNIX, INC. Topic: N/ADESCRIPTION (provided by applicant): Severe sepsis is a major cause of morbidity and mortality throughout the world. It is the leading cause of death in non-coronary intensive care units (ICUs) in the United States, with more than 750,000 cases occurring every year. This means that in the United States, more than 500 patients die from severe sepsis every day, with 28% to 50% of the patients succum ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
miRNA Profiling in Fixed Cancer Samples
SBC: AMBION DIAGNOSTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): During Phase I of our proposed research, we will develop and validate procedures for recovering, labeling, and analyzing miRNAs from fixed tissue samples. The procedures will be based on the miRNA microarray and fix ed tissue RNA isolation systems that we developed in other SBIR-funded programs. The development of our miRNA isolation and labeling procedures ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Dynamic Keyboard Systems for Improved Typing Performance
SBC: APPLIED HUMAN FACTORS INC Topic: N/ADESCRIPTION (provided by applicant): Dramatic increases in computer speed and the development of on-screen keyboards that send text to commercial software programs provided the foundation for this innovative approach to assisted typing. In Phase I, this new approach "Smart Key Technology (TM)" (SKT) was investigated, further developed, and tested. Using "letter p ...
SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health -
Microchips of Protein Kinase Substrates
SBC: ATACTIC TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): This is a SBIR Phase II application for developing microfluidic microchips containing 30k protein kinase (PK) substrate peptides for proteomic PK profiling of cell lysates. In recent years there has been a dramatic expa nsion in our understanding of PK (kinome) biology.1-7 In addition to the fundamental role of PKs in protein post-translational modification and ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Laser Cather for Ablation of Ventricular Tachycardia
SBC: Biotex, Inc. Topic: N/AN/A
SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health -
High Permeability, Long-Wear Contact Lens Materials
SBC: COMPACT MEMBRANE SYSTEMS, INC. Topic: N/AN/A
SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health -
3D Hybrid Optoacoustic-Ultrasonic System for Diagnostic Imaging of Breast Cancer
SBC: FAIRWAY MEDICAL TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): The objective of this project is to develop a new advanced imaging system to allow visualization of small cancerous tumors in situ based on combination of two types of tissue contrast: (1) molecular contrast of deoxygenated hemoglobin associated with the function of aggressive malignancy to develop angiogenesis and consume oxygen and (2) structural contrast ba ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
Designing Drugs That Supress Chronic Brain InFlammation
SBC: INFLAME THERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): The ultimate goal of treatment for Alzheimer's disease (AD) is to prevent degeneration of brain neurons and synapses. We screened a variety of generic drugs for neuroprotective effect using cell culture and animals mode ls of AD immune pathology. One widely used generic drug with anti-inflammatory properties was found to be highly neuroprotective in cell cultur ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
High Mass Resolution for MALDI TOF Mass Spectrometry
SBC: IONWERKS INC Topic: N/AN/A
SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health -
Electronic Smoking Cessation Monitor and Communicator
SBC: LIFETECHNIQUES, INC. Topic: N/ADESCRIPTION (provided by applicant): Nicotine addiction involves the coupling of smoking behaviors with multiple situational and environmental cues. Scheduled reduced smoking holds promise for decoupling the associations, achieving uncommonly high efficacy scores. Delivery of a personalized treatment schedule requires a programmable electronic device. This com ...
SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health